Along with additional Nordic companies, at the forthcoming live-streamed Redeye Life Science Day 2023, Richard will deliver an insight into Paxman followed by an in-depth 20-minute interview.
One-to-one meetings can also be facilitated.
 
When: November 23
Time: 08.00-16.00
Where: Live broadcast and special invitees only
Event link:
https://www.redeye.se/events/915984/redeye-life-science-day-2023

Contacts

Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 5,000 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK), Houston, Texas (US) and Toronto, Ontario (CA).

The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.

Attachments

Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023

© Modular Finance, source Nordic Press Releases